Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Ovarian cancer

  • You have access
    siPGK1 Sensitizes Chemoresistant Human Ovarian Cancer Cell Lines to Cisplatin
    CHARLOTTE LEPLEUX, EDWIGE ABEILARD-LEMOISSON, MARYLINE DUVAL, PHILIPPE ICARD and HUBERT LINCET
    Anticancer Research October 2012, 32 (10) 4277-4286;
  • You have access
    Clinical Outcome of Patients with Advanced Ovarian Cancer after Resection of Liver Metastases
    ULF P. NEUMANN, CHRISTINA FOTOPOULOU, MAXIMILIAN SCHMEDING, ARMIN THELEN, GEORGIOS PAPANIKOLAOU, ELENA I. BRAICU, PETER NEUHAUS and JALID SEHOULI
    Anticancer Research October 2012, 32 (10) 4517-4521;

Pages

  • Previous
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire